FIELD: medicine; cardiology.
SUBSTANCE: invention can be applied for prevention of immunodependant complications for cardiosurgery patients in postoperative period. For this purpose 7-10 days before operation self-restricted bone marrow cells (BMC) are sampled. Mononuclear fraction BMC is marked out in vitro. It is cultivated in gas medium within 7 to 10 days and introduced to patient during operation intramyocardially or intracoronary.
EFFECT: invention provides reparative regeneration of myocardium and reduction of infection-septic complications and organ dysfunctions.
2 tbl, 4 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTING ORGANISM RESISTANCE TO STRESS ACTION | 2006 |
|
RU2322675C1 |
| METHOD OF CHRONIC CARDIAC INSUFFICIENCY MEDICAL TREATMENT | 2006 |
|
RU2325934C1 |
| METHOD FOR PREDICTION OF SEPSIS FOLLOWING CARDIOSURGICAL OPERATIONS PERFORMED IN CONDITIONS OF ARTIFICIAL BLOOD CIRCULATION | 2019 |
|
RU2713930C1 |
| METHOD FOR TREATING PATIENTS WITH THE DEFECTS OF CARDIAC VALVES | 2006 |
|
RU2311140C1 |
| METHOD FOR TREATING CHRONIC DISEASES (VARIANTS), METHOD FOR OBTAINING A BIOTRANSPLANT (VARIANTS), A BIOTRANSPLANT (VARIANTS) | 2006 |
|
RU2322248C2 |
| METHOD FOR PREVENTING ENDOMETRITIS AS CONSEQUENCE OF CESAREAN SECTION | 1996 |
|
RU2133623C1 |
| METHOD OF PREVENTION OF POSTOPERATIVE SUPPURATIVE AND SEPTIC COMPLICATIONS IN CARDIOSURGERY | 2007 |
|
RU2350329C1 |
| METHOD FOR LABORATORY VERIFICATION OF INFECTIONS IN PATIENTS WITH ACUTE MANIFESTED MYELOID LEUKEMIA | 2011 |
|
RU2462711C1 |
| METHOD FOR PREDICTION OF POSTOPERATIVE COMPLICATIONS IN ONCOLOGICAL PATIENTS | 2008 |
|
RU2384297C1 |
| CELL-BASED THERAPY OF ISCHEMIC TISSUE | 2009 |
|
RU2535966C2 |
